Miriam Adelson Selected Research

Methadone (Dolophine)

1/2021	Polymorphisms in Stress-Related Genes Are Associated with Reduced Cocaine Abuse and Longer Retention in Methadone Maintenance Treatment for Opioid Use Disorder.
1/2021	The prevalence of constipation and its relation to sweet taste preference among patients receiving methadone maintenance treatment.
1/2021	Post-traumatic stress disorder due to sexual abuse and its relation to pain sensitivity among patients in methadone maintenance treatment.
12/2020	Improvement in Cognitive Performance after One Year of Methadone Maintenance Treatment.
1/2020	Drug Abuse and Behavioral Transgressions during Methadone Maintenance Treatment (MMT) are Related to High Psychopathy Levels.
1/2020	Educational lectures enhance knowledge about the human immunodeficiency virus (HIV) and reduce risky behavior and fear among methadone maintenance treatment patients.
11/2019	Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction.
10/2019	Outcome of Patients With High Depressive Symptoms on Admission to Methadone Maintenance Treatment.
1/2019	Cognitive function is largely intact in methadone maintenance treatment patients.
1/2018	Knowledge about nutrition, eating habits and weight reduction intervention among methadone maintenance treatment patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miriam Adelson Research Topics

Disease

24	Opioid-Related Disorders (Opiate Addiction) 01/2021 - 02/2005
14	Substance-Related Disorders (Drug Abuse) 12/2020 - 02/2005
12	Hepatitis C 01/2018 - 01/2004
11	Cocaine-Related Disorders (Cocaine Addiction) 01/2021 - 01/2006
9	Heroin Dependence (Heroin Abuse) 01/2021 - 07/2008
8	Mental Disorders (Mental Disorder) 01/2018 - 08/2003
7	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 09/2016 - 07/2009
7	Chronic Pain 09/2016 - 02/2005
6	Pain (Aches) 07/2021 - 02/2005
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2016 - 01/2012
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 09/2014
3	Weight Gain 01/2021 - 10/2016
3	Communicable Diseases (Infectious Diseases) 07/2015 - 01/2006
3	Gambling (Pathological Gambling) 12/2014 - 07/2009
2	Cognitive Dysfunction 01/2019 - 12/2014
2	Alcoholism (Alcohol Abuse) 01/2018 - 11/2015
2	Birth Weight (Birth Weights) 03/2017 - 03/2012
2	Genetic Predisposition to Disease (Genetic Predisposition) 05/2015 - 01/2015
2	Wounds and Injuries (Trauma) 09/2014 - 01/2012
2	Hepatitis B 03/2010 - 01/2007
1	Psychotic Disorders (Schizoaffective Disorder) 04/2022
1	Schizophrenia (Dementia Praecox) 04/2022
1	Constipation 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Overweight 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Sleepiness 01/2017
1	Hyperalgesia 09/2016
1	Long QT Syndrome 11/2013
1	Dissociative Identity Disorder (Multiple Personalities) 12/2012
1	Infections 09/2011
1	Neoplasms (Cancer) 03/2010
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 07/2008
1	Torsades de Pointes (Torsade de Pointes) 02/2007
1	Sleep Wake Disorders 04/2006
1	Marijuana Abuse (Cannabis Abuse) 01/2004

Drug/Important Bio-Agent (IBA)

45	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 04/2022 - 01/2004
44	Methadone (Dolophine)FDA LinkGeneric 01/2021 - 08/2003
17	BenzodiazepinesIBA 11/2019 - 01/2006
10	Opiate AlkaloidsIBA 01/2018 - 01/2007
10	Heroin (Diamorphine)IBA 01/2016 - 02/2007
9	Cocaine (Cocaine HCl)IBA 11/2019 - 04/2007
6	Pharmaceutical PreparationsIBA 01/2016 - 01/2007
4	Opioid Analgesics (Opioids)IBA 01/2017 - 02/2011
2	Pregabalin (Lyrica)FDA Link 07/2021 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2011
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 11/2019
2	Long Noncoding RNAIBA 01/2019 - 01/2018
2	AmphetaminesIBA 01/2008 - 04/2007
2	Dronabinol (THC)FDA LinkGeneric 01/2008 - 04/2007
1	Vitamin D FDA LinkGeneric 01/2021
1	VitaminsIBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2019
1	Hormones (Hormone)IBA 11/2019
1	3' Untranslated Regions (3' UTR)IBA 01/2019
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018
1	Buprenorphine (Subutex)FDA LinkGeneric 03/2017
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2016
1	Cholinergic ReceptorsIBA 01/2016
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	Monoamine Oxidase (MAO)IBA 01/2016
1	Muscarinic M4 ReceptorIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 11/2015
1	Neurotensin Receptors (Neurotensin Receptor)IBA 11/2015
1	Methylphenidate (Ritalin)FDA LinkGeneric 07/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 07/2015
1	Dopamine (Intropin)FDA LinkGeneric 05/2015
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2015
1	N-sulfo-2-aminotricarballylate (SATC)IBA 09/2014
1	Oxytocin Receptors (Oxytocin Receptor)IBA 07/2014
1	Galanin Receptors (Galanin Receptor)IBA 07/2014
1	HIV AntibodiesIBA 01/2014
1	Potassium Channels (Potassium Channel)IBA 11/2013
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 07/2013
1	Nicotine FDA Link 01/2012
1	Pain-FreeIBA 01/2011
1	mu Opioid Receptors (mu Opioid Receptor)IBA 07/2008
1	Amitriptyline (Elavil)FDA LinkGeneric 03/2008
1	benzoylecgonineIBA 04/2007
1	Hepatitis B AntigensIBA 01/2007

Therapy/Procedure

1	Precision Medicine 01/2021
1	Reducing Diet 01/2018
1	Self Medication 07/2015
1	Duration of Therapy 12/2014
1	Therapeutics 11/2013
1	Analgesia 02/2011